Reaction
Cluster Headache reporting signals
As of the last recalculation, Cluster Headache appears in 1,343 FAERS reports alongside 21 co-occurring drug terms. The strongest observed disproportionality signal is GALCANEZUMAB-GNLM (PRR 72.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Galcanezumab-Gnlm | 133 | 72.5 | 72.8 |
| Sumatriptan Succinate | 64 | 41.2 | 41.3 |
| Sumatriptan | 70 | 30.0 | 30.0 |
| Eptinezumab-Jjmr | 14 | 24.1 | 24.1 |
| Indomethacin | 16 | 18.9 | 18.9 |
| Amphetamine | 10 | 18.9 | 18.9 |
| Amitriptyline Hydrochloride | 18 | 16.1 | 16.1 |
| Ketoprofen | 11 | 13.1 | 13.1 |
| Fremanezumab-Vfrm | 8 | 10.9 | 10.9 |
| Topiramate | 61 | 10.6 | 10.6 |
| Acetaminophen, Aspirin (Nsaid) And Caffeine | 11 | 10.1 | 10.1 |
| Rimegepant Sulfate | 7 | 8.6 | 8.6 |
| Acetaminophen, Aspirin, And Caffeine | 11 | 8.1 | 8.2 |
| Erenumab-Aooe | 28 | 8.0 | 8.0 |
| Naltrexone Hydrochloride And Bupropion Hydrochloride | 4 | 7.3 | 7.3 |
| Sodium Oxybate | 30 | 7.2 | 7.2 |
| Ethyl Alcohol | 10 | 5.7 | 5.7 |
| Asenapine Maleate | 3 | 5.4 | 5.4 |
| Diroximel Fumarate | 3 | 3.9 | 3.9 |
| Buprenorphine | 21 | 3.6 | 3.6 |
| Abaloparatide | 6 | 3.2 | 3.2 |